MCTN‐IRF5 Treatment Depletes Immunosuppressive Tumor‐Associated Macrophages While Increasing Cytotoxic CD8+ T‐Cell Infiltration of the Tumor Microenvironment. The gene discussed is CD8A; the disease is neoplasm.